s3-e17.1 - potential breakthrough in anti-fibrotic therapies through mrna/car-t combined therapies
Published 2 years ago • 18 plays • Length 15:04Download video MP4
Download video MP3
Similar videos
-
1:13:49
s3-e17 - new in nash science: car-t/mrna anti-fibrotics and advanced nash omics
-
14:25
s3-e17.2 - future targeted nash therapies and nash drug development today
-
15:49
s3-e17.3 - spatial transcriptomics and the history of single cell genomics
-
3:14
car t-cell therapy explained (manufacturing process & how it works)
-
59:27
updates in car t cell therapies
-
1:51
car t cell therapy for cancer treatment: how it works
-
6:13
lymphoma: overview of chimeric antigen receptor (car) t cells
-
8:42
immunotherapy: the path to a cancer cure (for clinicians)
-
20:18
bwts tro troubleshooting guide
-
1:06:30
car-t cell therapy: a new chapter in lupus treatment?
-
0:45
side effects of car t-cell therapy
-
1:45
absorb iii trial: two-year outcomes - acc.17
-
3:10
tresr trial: novel atr inhibitor, rp-3500, for advanced solid tumors
-
1:33
a look at how car-t cell therapy works
-
0:47
dr. arteaga on pi3k pathway inhibitors
-
0:32
incognito™ appliance system clinical guide 07: lasso elastic (o lasso)
-
1:20
limitations of car t-cell therapy for dlbcl
-
3:58
manufacturing car t cells to accelerate cancer immunotherapy research
-
2:41
low level alkalinity titration part 3 - run a standard
-
2:43
manufacturing of car t-cells: new approaches
-
1:28
swiss lithoclast® trilogy lithotripter: empty the cooling liquid circuit
-
2:21
car t-cell therapy: how does it work?